Evidence map›Paper›PMID 23388409›Full record

Trial reportBrain : a journal of neurology2013

Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.

T Klopstock, G Metz, P Yu-Wai-Man, B Büchner, C Gallenmüller, M Bailie, N Nwali, P G Griffiths, B von Livonius, L Reznicek and 4 more

Registry-linked trialOpen access · hybridAbstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in Brain : a journal of neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01421381 (A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial), which is not on this map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01421381 completednot on this map

A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial

TypeobservationalSponsorSanthera PharmaceuticalsRan2011 to 2011Enrolled60ConditionsLeber's Hereditary Optic Neuropathy
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Therapies for Mitochondrial Disease: Past, Present, and Future.Journal of inherited metabolic disease · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

T Klopstock
G Metz
P Yu-Wai-Man
B Büchner
C Gallenmüller
M Bailie
N Nwali
P G Griffiths
B von Livonius
L Reznicek
J Rouleau
N Coppard
T Meier
P F Chinnery
Friedrich Baur Stiftung · DELudwig-Maximilians-Universität München · DE

Funding

Medical Research Council G0701386Medical Research Council G1002570Medical Research Council MR/K000608/1Wellcome Trust 096919Wellcome Trust 101876
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedCohort StudiesDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleMiddle AgedOptic Atrophy, Hereditary, LeberTime FactorsTreatment OutcomeUbiquinoneVisual AcuityYoung AdultidebenoneUbiquinone

Identifiers

PMID23388409
PMCPMC3572931
OpenAlexW2112249409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.